Maria Elisa Mancuso, MD brings years of leadership experience with the WFH to her new role. She has contributed to the WFH by advancing clinical research and helping shape evidence-based approaches to improving care for people with bleeding disorders worldwide.
Maria Elisa Mancuso, MD, is a member of several scientific societies and she is involved as medical member in the Extremely Rare & Inhibitor (ERIN) Working Group of the European Hemophilia Consortium (EHC). She is the Chair of the Medical Advisory Group of the EHC and president elect of the Italian Association of Hemophilia Centers (AICE). She has acted as co-chair of the Scientific and Standardization Subcommittee of the ISTH on FVIII, FIX and rare bleeding disorders.
Maria Elisa Mancuso is a hematologist and works as a Senior Hematology Consultant at the Centre for Thrombosis and Hemorrhagic Diseases of IRCCS Humanitas Research Hospital in Rozzano, Milan, Italy. She is Adjunct Clinical Professor at Humanitas University. She obtained a post-degree in Clinical and Experimental Hematology and a PhD in Clinical Methodology. She is involved in clinical research and has published several original articles in peer-reviewed journals such as New England Journal of Medicine, The Lancet, Lancet Hematology, Blood, Blood Advances, the Journal of Thrombosis and Haemostasis, Haematologica, Thrombosis and Haemostasis, and the British Journal of Haematology and Haemophilia.
Maria Elisa Mancuso’s invaluable experience will continue to be a great asset to the WFH as a Medical Member. Please join us in welcoming her to the WFH Board of Directors.
To find out more about WFH governance and the WFH Board of Directors, please click here.
